verified SJR 0,964 · Q2 • database Scopus / SJR & Web of Science indexed

Singapore · Elsevier (Singapore) Pte Ltd

workspace_premium Q2 — Gastroenterology lock Subscription

Hepatobiliary and Pancreatic Diseases International

Hepatobiliary and Pancreatic Diseases International is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 59. It has an SJR impact factor of 0,964 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,964.

ISSN: 1499-3872

Publisher: Elsevier (Singapore) Pte Ltd

Category: Gastroenterology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,964 Q2

H-index 59

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,964

H-index

Docs (year)

133

Docs 3y

320

Total refs

4756

Cites 3y

747

Citable 3y

174

Cites/Doc 2y

2.46

Ref/Doc

35.76

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Continuous regional arterial infusion for the treatment of severe acute pancreatitis: a meta-analysis

WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells

Early lactate clearance as a reliable predictor of initial poor graft function after orthotopic liver transplantation

Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation

Disease spectrum and use of cholecystolithotomy in gallstone ileus

Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection

Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions

Different cava reconstruction techniques in liver transplantation: piggy-back versus cava resection: The Author Reply

Different cava reconstruction techniques in liver transplantation: piggy-back versus cava resection

Diagnostic and prognostic roles of soluble CD22 in patients with Gram-negative bacterial sepsis

Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model

CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer

SHOW MORE ARTICLES

Critical role of estrogen in the progression of chronic liver diseases

18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice

China organ donation and transplantation update: the Hangzhou Resolution

CADM1 regelates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma

Blunt abdominal injury with rupture of giant hepatic cavernous hemangioma and laceration of the spleen

Bio-compatibility and cytotoxicity studies of water-soluble CuInS2-ZnS-AFP fluorescence probe in liver cancer cells

Assessment of clinical outcomes of advanced hilar cholangiocarcinoma

Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity

Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases

Aberrant methylation frequency of TNFRSF10C Promoter in pancreatic cancer cell lines

A selective approach to the surgical management of periampullary cancer patients and its outcome

A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experience

FAQs

Hepatobiliary and Pancreatic Diseases International has an SJR of 0,964 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Hepatobiliary and Pancreatic Diseases International is 30%.

Hepatobiliary and Pancreatic Diseases International

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Hepatobiliary and Pancreatic Diseases International?

What is the APC / publication cost?

What is the acceptance rate?